{"id":"W2118058941","doi":"10.1111/j.1365-4632.2007.03158.x","title":"Transitioning patients from efalizumab to alternative psoriasis therapies: findings from an open‐label, multicenter, Phase IIIb study","year":2007,"lang":"en","type":"article","venue":"International Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research","funders":"Genentech; Abbott Laboratories","keywords":"Medicine; Efalizumab; Dermatology; Psoriasis; Multicenter study; Open label; Plaque psoriasis; Clinical trial; Surgery; Internal medicine; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000178532,0.0002615696,0.0005217607,0.0003881099,0.000151536,0.00008765954,0.00121088,0.0001729294,0.0005800746],"category_scores_gemma":[0.00009459796,0.0002290573,0.00009378033,0.0001046926,0.00006466871,0.0005465252,0.0001383329,0.0002454728,0.0001160487],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001482008,"about_ca_system_score_gemma":0.00006293872,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006212527,"about_ca_topic_score_gemma":0.0003624193,"domain_scores_codex":[0.9978887,0.0003828347,0.0008992086,0.0003410861,0.0001836645,0.0003044917],"domain_scores_gemma":[0.9982262,0.0004387202,0.0004657297,0.000195789,0.0005812307,0.00009238117],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.05926773,0.03931962,0.3882987,0.00000502183,0.02045574,0.005606126,0.07217221,0.00001634706,0.1458433,0.0004240563,0.001994198,0.2665969],"study_design_scores_gemma":[0.2841984,0.01296361,0.3237042,0.0004054717,0.001780554,0.001900391,0.01708518,0.00004300112,0.331316,0.001966382,0.02307512,0.0015617],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9904879,0.0003549963,0.002623547,0.00079491,0.004858426,0.0003941472,0.0003718789,0.0000195843,0.00009457013],"genre_scores_gemma":[0.9975293,0.00003848007,0.001268976,0.0004988381,0.0001901045,0.00001362176,0.0004004116,0.00002511357,0.0000351366],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2650352,"threshold_uncertainty_score":0.9340684,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03201650071560092,"score_gpt":0.3476767070902343,"score_spread":0.3156602063746334,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}